NANCY MURPHY: Open Payments
NPI 1912075086 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 11 payments from 10 companies in 2025. Trend: 2023 $60 · 2024 $218 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Exact Sciences Corporation | 1 | $30 |
| Insulet Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
Products named: JARDIANCE, Kerendia, Cologuard Collection Kit, Omnipod, MOUNJARO, VOQUEZNA, VIVITROL, LEQVIO.
Industry payments across NY — which companies pay providers there.
